Skip to main content
Fig. 2 | BMC Cancer

Fig. 2

From: Assessing the impact of MRI based diagnostics on pre-treatment disease classification and prognostic model performance in men diagnosed with new prostate cancer from an unscreened population

Fig. 2

Simulated Kaplan–Meier curves for prostate-cancer-specific survival based on applying MRI adjustments to a previously described population cohort dataset of 10,139 men with long-term survival outcomes [24] A. European Association of Urology (EAU) 3-tier risk model B. American Urological Association (AUA) 4-tier risk model C. UK National Institute for Health and Care Excellence – Cambridge Prognostic Group 5-tier (CPG) prognostic model

Back to article page